Dont miss SGLT Tools - PowerPoint slide library for SGLT2 inhibitors

Ask the Experts

  1. alan friedman
  2. General Nephrology Questions
  3. Sunday, 13 January 2019
  4.  Subscribe via email
I am a practicing nephrologist in US starting to think that I should be adding spironolactone - even low dose - to an ARB or an ACEI for most nephrotic syndromes, and for diabetic nephropathy - if the potassium can still be controlled then what is the harm? any thoughts ? thank you
Responses (2)
Accepted Answer Pending Moderation
I agree completely. It will be very interesting to see the results of the clinical trial with finerenone added to ACEi or ARB, seen here:

Dr. Jordan Weinstein
  1. more than a month ago
  2. General Nephrology Questions
  3. # 1
Accepted Answer Pending Moderation
thank you appreciated !
  1. more than a month ago
  2. General Nephrology Questions
  3. # 2
  • Page :
  • 1

There are no replies made for this post yet.
Be one of the first to reply to this post!
Submit Your Response
Upload files or images for this discussion by clicking on the upload button below. Supports gif,jpg,png,zip,rar,pdf,jpeg,doc,docx,xls,xlsx
• Insert • Remove Upload Files (Maximum File Size: 10 MB) - NB: PLEASE REMOVE ALL IDENTIFYING DATA